Arjo AB header image

Arjo AB

ARJO B

Equity

ISIN SE0010468116 / Valor 39115843

NASDAQ Nordic Exchange Stockholm, Equities (2025-10-21)
SEK 31.40+1.03%

Arjo AB
UMushroom community rating:

star star star star star
2.00 1 votes No rating yet
NegativeNeutralPositive

About company

Arjo AB, founded in 1957 by Arne Johansson in Eslöv, Sweden, is a global provider of medical devices and solutions aimed at enhancing patient care and mobility. Headquartered in Malmö, Sweden, the company specializes in products and services that facilitate patient transfers, hygiene, disinfection, and the prevention of pressure injuries and deep vein thrombosis. Additionally, Arjo offers medical beds and provides training services related to its product offerings. With a workforce of approximately 6,500 employees, the company operates five product development and production units worldwide and reported net sales of around SEK 11 billion in 2023. Arjo's products and services are available in over 100 countries, underscoring its extensive global reach in the healthcare sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (18.10.2025):

Arjo AB reported net sales of approximately SEK 11 billion for the year 2024, showcasing its strong position in the sustainable healthcare market.

Net Sales Performance

In 2024, Arjo AB achieved net sales of about SEK 11 billion, reflecting its commitment to expanding high-quality care solutions globally.

Interim Reporting

The company has announced interim reports for January–June 2025 and January–September 2025, providing insights into its ongoing financial performance and strategic initiatives.

Dividend Announcement

Arjo AB proposed a record date for dividend distribution, highlighting its dedication to delivering value to shareholders.

Summarized from source with an LLMView Source

Key figures

-14.0%1Y
-31.6%3Y
-47.9%5Y

Performance

26.6%1Y
33.7%3Y
36.3%5Y

Volatility

Market cap

847 M

Market cap (USD)

Daily traded volume (Shares)

755,634

Daily traded volume (Shares)

1 day high/low

35.48 / 34.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Gian Mattmüller
Switzerland, 17 Oct 2025
star star star star star
.

EQUITIES OF THE SAME SECTOR

Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.57%CHF 60.26
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%CHF 88.54
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.88%CHF 3.71
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%CHF 311.00
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%CHF 13.10
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.05%CHF 5.92
Xlife Sciences Ltd.
Xlife Sciences Ltd. Xlife Sciences Ltd. Valor: 46192960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.92%CHF 20.40
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.46%CHF 0.81
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.70%CHF 14.34
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%EUR 21.10